STOCK TITAN
  1. Home
  2. CANB

CAN B (CANB) Stock Price, News & Analysis

CANB OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
163 245 sessions, September 13, 2024 to September 15, 2025
Largest daily move
+131.3% close of September 23, 2024
1-year change
+74.8% closing prices, September 13, 2024 to September 15, 2025
1-month change
-12.6% closing prices, August 15, 2025 to September 15, 2025

Company Description

CAN B (OTC: CANB) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.4M.

CANB has gained 74.8% over the past year. The last closing price was $0.0180.

For FY2023, CAN B reported revenue of $2.2M with net income of -$9.7M and diluted earnings per share of -$0.77.

This page collects what Stock Titan holds for CANB, including price data, latest news, and financial highlights.

Stock Performance

Chart
$—
-
-
Last updated:
+74.8%
Performance 1 year
$1.4M
Market Cap
78.0M
Shares outstanding

CAN B (CANB) closed at $0.0180 on September 15, 2025. Over the past 12 months, the price has gained 74.8%.

See what a $1,000 investment in CANB would be worth today

Average down calculator for CANB

CANB Metrics & Rankings

Market Cap
$1.4M
View ranking
Piotroski F-Score
1/9
#7,717
Month to date
-10.0%
View ranking
YTD
-49.6%
View ranking

Price returns through September 15, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
+18.75%

Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company

-11.11%

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million

-0.71%

Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado

-36.89%

Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising

+1.96%

Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue

-7.69%

Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange

-31.43%

Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History

earnings
+0.84%

Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.

+3.63%

Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History

+8.00%

Can B Corp. to Present at the Emerging Growth Conference on Wednesday, April 27, 2022

conferences

CAN B has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all CANB news →

SEC Filings

View All

No SEC filings available for CANB.

Financial Highlights

View Full Financials

CAN B generated $2.2M in revenue in FY2023, retaining a 16.6% gross margin, operating income reached -$7.5M, and net income was -$9.7M. Diluted earnings per share stood at -$0.77. The company generated -$1.3M in operating cash flow. The current ratio was 0.45, measuring current assets divided by current liabilities.

$2.2M
Revenue (FY2023)
-$9.7M
Net Income (FY2023)
-$0.77
Diluted EPS (FY2023)
-$1.3M
Operating Cash Flow
16.6%
Gross Profit Margin
0.45
Current Ratio

Upcoming Events

Related Stocks

CBDD CBD OF DENVER INC
1.7M
OVATF OVATION SCIENCE INC
288.3K
SFWJ SOFTWARE EFF SLTNS CORP
988.4K
CVGRF CITY VIEW GREENN HLDGS
1.3M
WIBFF WEST ISLAND BRANDS INC
1.5M
PLSH PANACEA LIFE SCIENCE HLD
4.7M
CBDL CBD LIFE SCIENCES INC
916.6K
HEMP HEMP INC
1.2M

CANB Company Profile & Sector Positioning

CAN B (CANB) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing CANB often look at related companies in the same sector, including CBD OF DENVER INC (CBDD), OVATION SCIENCE INC (OVATF), SOFTWARE EFF SLTNS CORP (SFWJ), CITY VIEW GREENN HLDGS (CVGRF), and WEST ISLAND BRANDS INC (WIBFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANB's relative position within its industry.

Frequently Asked Questions

What is the current stock price of CAN B (CANB)?

The current stock price of CAN B (CANB) is $0.018 as of September 15, 2025.

What is the market cap of CAN B (CANB)?

The market cap of CAN B (CANB) is approximately $1.4M. Learn more about what market capitalization means .

What is the revenue of CAN B (CANB) stock?

The FY2023 revenue of CAN B (CANB) is $2.2M, from its most recent completed fiscal year.

What is the net income of CAN B (CANB)?

The FY2023 net income of CAN B (CANB) is -$9.7M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of CAN B (CANB)?

The diluted earnings per share (EPS) of CAN B (CANB) is -$0.77 for FY2023, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of CAN B (CANB)?

The operating cash flow of CAN B (CANB) is -$1.3M for FY2023, its most recent completed fiscal year. Learn about cash flow.

What is the gross margin of CAN B (CANB)?

The gross profit margin of CAN B (CANB) is 16.6% for FY2023, its most recent completed fiscal year. Learn about gross margins.

What is the current ratio of CAN B (CANB)?

The current ratio of CAN B (CANB), current assets divided by current liabilities, was 0.45 at the end of FY2023, its most recent completed fiscal year. Learn about liquidity ratios.

What is the gross profit of CAN B (CANB)?

The gross profit of CAN B (CANB) is $359K for FY2023, its most recent completed fiscal year.

What is the operating income of CAN B (CANB)?

The operating income of CAN B (CANB) is -$7.5M for FY2023, its most recent completed fiscal year. Learn about operating income.